65,437 trials
High Cholesterol
Primary: Lipid Profile — -5; -5; 2; -4 mg/dl
Neisseria Meningitidis · Haemophilus Influenzae Type b
Primary: Number of Subjects With Anti-polyribosyl-ribitol-phosphate (Anti-PRP) Concentration Greater Than or Equal to 1.0 Microgram Per Milliliter (µg/mL) — 255; 76 Participants
Renal Cell Carcinoma
Primary: Response Rate — 1; 9.4; 12.6; 76.8 Percentage of participants
Atherosclerosis
Primary: Percent Cross-sectional Area of Macrophages in Plaque Tissue — 8.08; 8.19 Percent Area — p=0.97
Multiple Myeloma
Primary: Recommended Phase II Dose (RP2D) of the Combination (Dasatinib + Lenalidomide + Dexamethasone) — 140; 25; 40 mg
Neisseria Meningitidis · Haemophilus Influenzae Type b
Primary: Number of Subjects With Anti- Polyribosylribitol Phosphate (Anti-PRP) Antibody Concentrations Greater Than or Equal to 0.15 Microgram Per Milliliter — 116; 49; 46; 60…
Coronary Artery Bypass Graft · Cardiopulmonary Bypass
Primary: Incidence of Adverse Events — 3; 3; 5; 4 participants
Limited Stage Small Cell Lung Cancer
Primary: Overall Survival — 21 months
Arthritis, Juvenile Idiopathic
Primary: Percentage of Participants With an American College of Rheumatology Pediatric 30 (ACR Pedi 30) Response at Week 12 — 88.6 Percentage of participants
Perennial Allergic Rhinitis
Primary: Serum Cortisol Area Under the Concentration-time Curve (AUC)(0-24h) at Baseline — 183.2; 171.7; 173.1; 172.8 mcg•h/dL
Surgical Incisions
Primary: Continuous Apposition of the Skin Edges Without Wound Dehiscence or Re-closure as Measured by the Upper Limit of 95% Confidence Interval in Proportion of Successes for…
Macromastia
Primary: Continuous Apposition of the Skin Edges Without Wound Dehiscence or Re-closure as Measured by the Upper Limit of 95% Confidence Interval in Proportion of Successes for…
Influenza
Primary: The Percentage of Evaluable Participants Achieving Seroconversion or Significant Increase in Antibody Titre. — 91.7; 53.4; 93.3; 63.8 percentage of participants
Diabetes Mellitus, Type 2
Primary: HbA1c Change From Baseline to Week 24 — 0.04; -0.61 Percent — p=<0.0001
Cataract
Primary: Percentage of Staphylococcus Epidermidis Species Susceptible and Resistant to Oxacillin on the Eyelid — 51; 48 Percentage of Species